Monday, March 30, 2020

USFDA classifies Sun Pharma#39;s Halol manufacturing site for official action, may put all new approvals on hold

USFDA classifies Sun Pharma#39;s Halol manufacturing site for official action, may put all new approvals on hold The OAI status implies that the USFDA may put all new approvals from the Halol facility on hold till the outstanding corrective actions are completed.

from Moneycontrol Business News https://ift.tt/3artekw

No comments:

Post a Comment

US equities end lower as valuation concerns creep in

U.S. stocks closed lower on Wednesday as investors took profits amid concerns about high valuations flagged by Fed Chair Powell. The market ...